[go: up one dir, main page]

UA97099U - METHOD OF EVALUATION OF TREATMENT EFFICIENCY IN EXPERIMENTAL PERIODONTITIS - Google Patents

METHOD OF EVALUATION OF TREATMENT EFFICIENCY IN EXPERIMENTAL PERIODONTITIS

Info

Publication number
UA97099U
UA97099U UAU201411227U UAU201411227U UA97099U UA 97099 U UA97099 U UA 97099U UA U201411227 U UAU201411227 U UA U201411227U UA U201411227 U UAU201411227 U UA U201411227U UA 97099 U UA97099 U UA 97099U
Authority
UA
Ukraine
Prior art keywords
treatment
evaluation
treatment efficiency
experimental periodontitis
effectiveness
Prior art date
Application number
UAU201411227U
Other languages
Russian (ru)
Ukrainian (uk)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to UAU201411227U priority Critical patent/UA97099U/en
Publication of UA97099U publication Critical patent/UA97099U/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Спосіб оцінки ефективності лікування при експериментальному пародонтиті включає дослідження жирнокислотного складу ліпідів біологічного матеріалу за допомогою газорідинної хроматографії. Досліджують жирнокислотний склад ліпідів плазми крові і тканин пародонту, виявляють метаболічні зміни жирних кислот до і після лікування, порівнюють з контролем і оцінюють ефективність лікування.A method of assessing the effectiveness of treatment in experimental periodontitis involves the study of the fatty acid composition of the lipids of biological material using gas-liquid chromatography. Investigate the fatty acid composition of blood plasma lipids and periodontal tissues, identify metabolic changes in fatty acids before and after treatment, compare with control and evaluate the effectiveness of treatment.

UAU201411227U 2014-10-15 2014-10-15 METHOD OF EVALUATION OF TREATMENT EFFICIENCY IN EXPERIMENTAL PERIODONTITIS UA97099U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201411227U UA97099U (en) 2014-10-15 2014-10-15 METHOD OF EVALUATION OF TREATMENT EFFICIENCY IN EXPERIMENTAL PERIODONTITIS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201411227U UA97099U (en) 2014-10-15 2014-10-15 METHOD OF EVALUATION OF TREATMENT EFFICIENCY IN EXPERIMENTAL PERIODONTITIS

Publications (1)

Publication Number Publication Date
UA97099U true UA97099U (en) 2015-02-25

Family

ID=52990176

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201411227U UA97099U (en) 2014-10-15 2014-10-15 METHOD OF EVALUATION OF TREATMENT EFFICIENCY IN EXPERIMENTAL PERIODONTITIS

Country Status (1)

Country Link
UA (1) UA97099U (en)

Similar Documents

Publication Publication Date Title
MX2022007933A (en) Polymethine compounds and their use as fluorescent labels.
AR095856A1 (en) METHOD OF TREATMENT OF AN ANIMAL SUBSTRATE
CA2951514C (en) METHODS, COMPOSITIONS AND DEVICES FOR THE RAPID ANALYSIS OF BIOLOGICAL MARKERS
MX2017003790A (en) DETECTION OF DIANA SEQUENCES FOR PERCEPTION OF NANOPOROS OF SYNTHETIC PROBES.
UY34675A (en) ? PROCESS AND APPLIANCE TO TREAT METAL SURFACES ?.
BR112015005369A2 (en) usp30 inhibitors and methods for their use
MX2019009783A (en) METHOD TO MANUFACTURE A BAR THAT INCLUDES ANTI-TRANSPIRANT.
UY34800A (en) PHARMACEUTICAL COMBINATIONS CONTAINING AN INHIBITOR OF 11-BETA-HYDROXIESTEROID DEHYDROGENASE-1 USEFUL IN METABOLIC DISORDERS
CL2018002548A1 (en) Regulation of ornithine metabolism to increase the content of mannose-rich glycoforms of recombinant proteins. (Divisional application 201601786)
MX382116B (en) COMPOSITIONS COMPRISING 15-HYDROXYEICOSAPENTAENOIC ACID (15-HEPE) AND METHODS FOR TREATING OR PREVENTING FIBROSIS USING THE SAME.
UY36173A (en) METHOD OF TREATMENT OF DISEASES RELATED TO THE INDICATABLE FACTOR FOR HYPOXIA
EP3288550C0 (en) STRUCTURALLY IMPROVED SULFUR-CONTAINING FATTY ACIDS FOR THEIR USE IN THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS
BR112016010159A2 (en) uses of a nucleic acid pool and microarray chip, microarray chip, methods for detecting beneficial pathogens and / or microorganisms in an organic sample and treating a diseased grass, and
MX387903B (en) PROCESS FOR THE PREPARATION OF 3-HYDROXYPICOLINIC ACIDS.
BR112016028561A8 (en) composition and dosage form comprising a marine oil comprising fatty acids, and use thereof
CL2019003571A1 (en) Lipid comprising docosapentaenoic acid. (divisional application 3351-2016)
PH12016502311A1 (en) Omega-3 analogues
AR104805A1 (en) METHODS AND COMPOSITIONS TO EVALUATE CANCER RESPONSE RESPONSE TO BET INHIBITORS
AR099753A1 (en) COMPOSITION FOR USE AS AN ABNORMAL COAGULATION CONTROL PLASMA IN IN VITRO TESTS
MX2016015531A (en) Assay for oral inflammation.
UA97099U (en) METHOD OF EVALUATION OF TREATMENT EFFICIENCY IN EXPERIMENTAL PERIODONTITIS
EA201491455A1 (en) EFFECTORS β-ARRESTINA, COMPOSITIONS, THEIR CONTAINING, AND METHODS OF THEIR USE
BR112017007733A2 (en) method for quantifying a target nucleic acid, and, kit.
MX2017006747A (en) AMIDAS OF FATTY ACIDS FOR THE PREVENTION AND / OR TREATMENT OF ESTEATOHEPATITIS.
ES2528394B1 (en) Lignocellulosic biomass hydrolysis procedure